Quality, size, and composition of pediatric endobronchial biopsies in cystic fibrosis

Regamey, Nicolas; Hilliard, Thomas N; Saglani, Sejal; Zhu, Jie; Scallan, Mike; Balfour-Lynn, Ian M; Rosenthal, Marc; Jeffery, Peter K; Alton, Eric W F W; Bush, Andrew; Davies, Jane C (2007). Quality, size, and composition of pediatric endobronchial biopsies in cystic fibrosis. Chest, 131(6), pp. 1710-7. Northbrook, Ill.: American College of Chest Physicians 10.1378/chest.06-2666

Full text not available from this repository. (Request a copy)

BACKGROUND: Studies on airway remodeling in children with cystic fibrosis (CF) may be hampered by difficulty in obtaining evaluable endobronchial biopsy specimens because of large amounts of mucus and inflammation in the CF airway. We prospectively assessed how the quality of biopsy specimens obtained from children with CF compare with those from children with other airway diseases. METHODS: Fiberoptic bronchoscopy with endobronchial biopsy was performed in 67 CF children (age range, 0.2 to 16.8 years), 34 children with wheeze/asthma (W/A), and 64 control children with chronic respiratory symptoms. Up to three biopsy specimens were taken and stained with hematoxylin and eosin. Biopsy specimen size and structural composition were quantified using stereology. RESULTS: At least one evaluable biopsy specimen was obtained in 72% of CF children, in 79% of children with W/A, and in 72% of control subjects (difference was not significant). The use of large biopsy forceps (2.0 mm) rather than small biopsy forceps (1.0 mm) [odds ratio (OR), 5.8; 95% confidence interval (CI), 1.1 to 29.8; p = 0.037] and the number of biopsy specimens taken (odds ratio, 2.6; 95% confidence interval, 1.3 to 5.2; p = 0.006) significantly contributed to the success rate. Biopsy size and composition were similar between groups, except that CF children and those patients with W/A had a higher percentage of the biopsy specimen composed of muscle than did control subjects (median 6.2% and 9.7% vs 0.9%, respectively; p = 0.002). CONCLUSIONS: Biopsy size and quality are adequate for the study of airway remodeling in CF children as young as 2 months of age. Researchers should use large forceps when possible and take at least two biopsy specimens per patient. An increased airway smooth muscle content of the airway mucosa may contribute to the pathophysiology of CF lung disease.

Item Type:	Journal Article (Original Article)
Division/Institute:	04 Faculty of Medicine > Department of Gynaecology, Paediatrics and Endocrinology (DFKE) > Clinic of Paediatric Medicine
UniBE Contributor:	Regamey, Nicolas
ISSN:	0012-3692
ISBN:	17317731
Publisher:	American College of Chest Physicians
Language:	English
Submitter:	Anette van Dorland
Date Deposited:	04 Oct 2013 14:55
Last Modified:	05 Dec 2022 14:17
Publisher DOI:	10.1378/chest.06-2666
PubMed ID:	17317731
Web of Science ID:	000247336600017
URI:	https://boris.unibe.ch/id/eprint/23437 (FactScience: 41821)